HomeCancerProstate

Prostate

Evaluating Stereotactic vs. Typical Proton Remedy for Early Prostate Most cancers

The next is a abstract of “Stereotactic Physique Proton Remedy Versus Conventionally Fractionated Proton Remedy for Early Prostate Most cancers: A Randomized, Managed,...

Dr Grimm on Unmet Wants After Development to mCRPC Following ARPI Plus Chemo

Marc-Oliver Grimm, MD, professor, chairman, Division of Urology, Jena College Hospital, discusses the unmet wants for sufferers who progress to metastatic castration-resistant prostate...

Deprived Areas Linked to Aggressive Prostate Most cancers

BALTIMORE, MD, July 12, 2024 — These residing in deprived neighborhoods have considerably larger exercise of stress-related genes, new analysis suggests, which may...

An 18-gene signature of recurrence-associated endothelial cells predicts tumor development and castration resistance in prostate most cancers

Identification and validation of recurrence-associated endothelial cells utilizing a 54-gene panelAs step one in exploring the prognostic worth of TECs in PCa, we...

Hot Topics